The Consultant & Investment GroupAMM:CICO 77 Return-on-Tangible-Equity is 3.16% as of Mar. 2026, which is 37% below its 10-year median of 5.05. GuruFocus rates AMM:CICO with a GF Score™ of 77/100 and a GF Value™ of JOD2.20 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 581 Healthcare Providers & Services companies, The Consultant & Investment Group ranks worse than 58.35% on this metric.
The historical rank and industry rank for The Consultant & Investment Group's Return-on-Tangible-Equity or its related term are showing as below:
AMM:CICO'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -5.8 Med: 5.05 Max: 7.75
Current: 6.83
During the past 13 years, The Consultant & Investment Group's highest Return-on-Tangible-Equity was 7.75%. The lowest was -5.80%. And the median was 5.05%.
AMM:CICO's Return-on-Tangible-Equity is ranked worse than 58.35% of 581
companies
in the Healthcare Providers & Services industry
Industry Median: 9.93
vs AMM:CICO: 6.83
The Consultant & Investment Group (AMM:CICO) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
The Consultant & Investment Group Return-on-Tangible-Equity Related Terms
The Consultant & Investment Group Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Consultant & Investment Group Return-on-Tangible-Equity Chart
AMM:CICO vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, The Consultant & Investment Group's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Consultant & Investment Group Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, The Consultant & Investment Group's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where The Consultant & Investment Group's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 3.16% mean?
The Consultant & Investment Group (AMM:CICO) has a Return-on-Tangible-Equity of 3.16% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on The Consultant & Investment Group and its competitors. This is 37% below median its historical median of 5.05. According to the industry distribution chart, The Consultant & Investment Group ranks #339 out of 581 companies in the Healthcare Providers & Services industry, placing it in the top 58.3%.
Is The Consultant & Investment Group's Return-on-Tangible-Equity too high?
The Consultant & Investment Group's current Return-on-Tangible-Equity of 3.16% is 37% below median its 10-year median of 5.05. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 9.93. The Consultant & Investment Group's value of 3.16% is 68.2% below this industry median. Based on the distribution chart, The Consultant & Investment Group ranks #339 out of 581 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, The Consultant & Investment Group has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Consultant & Investment Group's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, The Consultant & Investment Group ranks #339 out of 581 companies for Return-on-Tangible-Equity. This places The Consultant & Investment Group in the lower half of its industry. The industry median Return-on-Tangible-Equity is 9.93. The Consultant & Investment Group's value of 3.16% is 68.2% below this benchmark. While the company's 10-year median is 5.05 vs. the industry median of 9.93, The Consultant & Investment Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 9.93, based on 581 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Consultant & Investment Group's current Return-on-Tangible-Equity of 3.16% is 68.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on The Consultant & Investment Group and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 9.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Consultant & Investment Group's current Return-on-Tangible-Equity is 3.16%, which is 37% below median its own 10-year median of 5.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Consultant & Investment Group stock overvalued right now?
Based on GuruFocus' analysis, The Consultant & Investment Group (AMM:CICO) is currently considered Modestly Undervalued. The stock's GF Value™ is JOD2.20, compared to a current price of JOD1.78 — trading 19.1% below its estimated fair value. The current Return-on-Tangible-Equity is 3.16%, which is 37% below median its 10-year median of 5.05 and 68.2% below the Healthcare Providers & Services industry median of 9.93. The Consultant & Investment Group's overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For The Consultant & Investment Group (AMM:CICO), the current Return-on-Tangible-Equity is 3.16% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Consultant & Investment Group (AMM:CICO) Overvalued in 2026?
Based on GuruFocus' analysis, The Consultant & Investment Group stock appears to be undervalued.
The current stock price of JOD1.78 is trading 19.1% below its estimated GF Value™ of JOD2.20.
GuruFocus considers The Consultant & Investment Group to be Modestly Undervalued.
Key valuation signals for AMM:CICO:
Return-on-Tangible-Equity: 3.16% (37% below median its 10-year median of 5.05)
GF Value™: JOD2.20 vs. price of JOD1.78 (19.1% below fair value)
Industry Position: 68.2% below the Healthcare Providers & Services median (#339 of 581)
No single metric tells the full story. See the AMM:CICO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
The Consultant & Investment Group Business Description
The Consultant & Investment Group is a Jordan-based company that engages in the healthcare and medical sector. It is engaged in the provision of medical care services. The company generates revenue from medical services and the sale of medicine and medical/ supplies are recognized. The company gains majority of revenue from Jordan. The Group principally operates only in the Hashemite Kingdom of Jordan.
77GF Score
Get the complete analysis for AMM:CICO
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMM:CICO has been successfully added to your 
